Related Topics News -

     
 Title only   |   Print 
     
《大行》花旗:中國製藥及生物科技ESMO數據再獲驗證 看好石藥、恆瑞、信達生物及科倫博泰

2026-11-02T  
科倫博泰生物核心產品TROP2 ADC獲中國受理新增適應症

2026-10-27T  
《大行》Bernstein:科倫博泰ESMO肺癌研究更新大獲成功 評級「跑贏大市」

2026-10-27T  
《大行》瑞銀:科倫博泰OptiTROP-L06數據具同類最佳潛力

2026-10-26T  
《大行》富瑞:科倫博泰sac-TMT肺癌一線數據亮麗

2026-10-26T  
《大行》里昂:美國擬禁生物科技對外投資影響有限 予科倫博泰「跑贏大市」評級

2026-10-26T  
《大行》匯豐研究對中國醫藥及生物科技股投資評級及目標價(表)

2026-09-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.